[{"NetIncomeLossConverted_1_Q3_USD":181739000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":222113000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":222248000.0,"CommonStockSharesConverted_0_Q3_shares":220885119.0,"Assets_0_Q3_USD":4198831000.0,"RevenuesConverted_3_Q3_USD":2123414000.0,"RevenuesConverted_1_Q3_USD":812987000.0,"EarningsPerShareBasic_3_Q3_USD":1.75,"StockholdersEquity_0_Q3_USD":3148657000.0,"EarningsPerShareDiluted_3_Q3_USD":1.73,"EarningsPerShareDiluted_1_Q3_USD":0.82,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":634137000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":220243000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":220845000.0,"NetIncomeLossConverted_3_Q3_USD":384730000.0,"CommonStockSharesOutstanding_0_Q3_shares":220885119.0,"EarningsPerShareBasic_1_Q3_USD":0.82,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20211102"}]